Mechanism behind PARP1-mediated DNA repair characterized, offering insight into targeted cancer therapy
Researchers at St. Jude Children's Research Hospital have identified a unique mechanism by which the enzyme PARP1 disassembles nucleosomes to facilitate DNA repair. This discovery provides new insights into how cells manage DNA damage and could lead to more effective targeted cancer therapies.
Why it matters
Understanding the fundamental mechanics of DNA repair is critical for developing drugs that exploit genetic vulnerabilities in cancer cells.
edited by Lisa Lock , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add to Preferred Sources Credit: Molecular Cell (2026). DOI: 10.1016/j.molcel.2026.09.040 When DNA is damaged, cellular processes respond and repair the DNA. Inhibiting DNA damage repair can be therapeutically beneficial in cancers with genetic vulnerabilities related to DNA damage response. Scientists at St. Jude Children's Research Hospital have uncovered a mechanism behind how this process works, which may have implications for cancer treatment. The results were published today in Molecular Cell .
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in